Splenectomy vs. rituximab as a second-line therapy in...

  • Main
  • 2017 / 9
  • Splenectomy vs. rituximab as a second-line therapy in...

Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience

Al Askar, Ahmed S., Shaheen, Naila A., Al Zahrani, Mohsen, Al Otaibi, Mohammed G., Al Qahtani, Bader S., Ahmed, Faris, Al Zughaibi, Mohand, Kamran, Ismat, Mendoza, May Anne, Khan, Altaf
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-017-2325-y
Date:
September, 2017
File:
PDF, 798 KB
english, 2017
Conversion to is in progress
Conversion to is failed